Le Lézard
Classified in: Health
Subject: CFG

Public Advisory - Unauthorized treatments provided by individual posing as a practitioner at MedSkin Laser Center in Sherwood Park, Alberta, may pose health risks


OTTAWA, ON, Aug. 2, 2024 /CNW/ -

Summary

Affected products

Issue

Health Canada is warning the public about various unauthorized treatments that were being administered at MedSkin Laser Center in Sherwood Park, Alberta, where the owner and operator of the clinic was posing as a practitioner without the necessary qualifications.

This includes the unauthorized Platelet Rich Plasma (PRP) treatments listed above for hair restoration, breast enhancements, rejuvenating skin and muscles, wound healing and face lifts. Unauthorized PRPs could lead to serious health risks, including the potential transmission of infectious diseases, contaminants, and toxic effects.

Health Canada also seized prescription Botox from the MedSkin Laser Centre, because prescription drugs should only be given by a health care professional with the appropriate qualifications and experience. Using prescription drugs without a proper prescription and the advice of a qualified practitioner could lead to serious harm such as side effects, allergic reactions, severe complications and other medical issues.

Finally, the Department also seized unauthorized medical devices including microneedles, microneedle tips, and a plasma pen.

What you should do 

Également disponible en français

SOURCE Health Canada (HC)


These press releases may also interest you

at 06:22
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some...

at 06:03
After a summer of excessive heat, massive flooding, raging wildfires and the earliest Category 5 hurricane ever recorded, communities and families are feeling the effects of the climate crisis ? and relying on the American Red Cross for support ? now...

at 05:45
, September 20, 2024 ? Levi & Korsinsky, LLP notifies investors in Agenus Inc. ("Agenus" or the "Company") of a class action securities lawsuit....

at 05:00
Olink Proteomics, part of Thermo Fisher Scientific, a leading provider of advances proteomics solutions, is exited to announce its upcoming virtual conference, Olink...

at 04:52
ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentationAdditionally, two posters on data from the pioneering use of tape stripping for biomarker analysis in the ADESOS study and additional ADESOS...

at 04:28
CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the company's leading clinical candidate, is...



News published on and distributed by: